Erowid Monthly
After months of mysterious, difficult-to-diagnose software and hardware issues, the time has come for Fire's hardworking desktop computer (named "Datura") to be replaced. It's had a solid run, but mission-critical hardware needs to be replaced when it starts experiencing problems. Please donate to the new computer fund and help us raise $2,500 this week!

Survey Participation Notice -- This International Drugs Survey is conducted by University College London and the Beckley Foundation:
Drug Geek Factlet
Naloxone and naltrexone, two opioid antagonists used to counteract opiate overdoses, were initially Schedule II in the US despite having no known recreational use. In the first version of the Controlled Substances Act, derivatives of thebaine were Schedule II, and Naloxone and Naltrexone are both thebaine-derived. They were de-scheduled in three steps in 1971, 1974 and 1975, making them two of only a handful of drugs ever to be de-scheduled. (see #1 below)
European Student Drug Policy Reform Conference (Mar 25-27, 2011) in Manchester, UK

Psychedelics in the Culture and Healing of the 21th Century (Mar 11-12, 2011) in Budapest
Latest Additions
In September 2010, a Drug Safety and Risk Management Advisory Committee of the FDA convened the newest governmental inquiry into the decades-old issue of DXM's abuse potential. Amusingly, one manufacturer singled out Erowid for blame.
These excerpts from Eveline Chao's book Niubi!: The Real Chinese You Were Never Taught in School provide some intriguing insight into Chinese vocabulary and slang related to psychoactive drugs and drug use.
Arrested in October 2010 for possession of ayahuasca in Texas, this Colombian shaman was en route to a ceremony in Oregon. Charges were dropped a month later leaving open questions of whether an indigenous shaman can lead ayahuasca ceremonies in the U.S.
Crew Notes
We just found out that The Shulgin Index came back from the printer and is in the hands of the Shulgin team. After years of work, it's done! Stay tuned for excerpts on Erowid soon! To order:

Also, we're getting close to a finalized version of a new ketamine survey that Erowid will be conducting with researchers from California Pacific Medical Center. Keep an eye out for it on the site.
From the Vaults
Between 2004 to 2007, Erowid published eScottology, a column by Scott O. Moore, a contributor to the psychoactives-related blog DoseNation. In this installment, Scotto describes his experience taking a year-long break from psychedelics.
More New Content
  1. Drugs that Have Been De-Scheduled in the U.S.
    A compilation of all of the controlled substances that have ever been removed from control at some point after having been scheduled. Turns out this is extremely uncommon!
  2. Agreement on Procedures for Handling UDV Sacrament
    July 2010 Agreement on Handling of Hoasca (PDF)

    A July 2010 Agreement (21-page PDF) between the DEA and UDV defining how ayahuasca destined for US UDV ceremonies is handled, with Feb 2011 commentary by US UDV president Jeffrey Bronfman.
Ecstasy Data
EcstasyData is a project of Erowid Center that conducts laboratory testing of street Ecstasy tablets and publishes these and other test results online.
Donate Or Become A Member
If you find Erowid a useful resource and are interested in supporting its future development, please consider donating or becoming a member. Donations to Erowid Center are tax-deductible in the United States.
List Subscription Information
  • To UNSUBSCRIBE - send an empty email to:
  • To SUBSCRIBE - send an empty email to: